RE:TATRUTIDE

R1 800,00

• Possibilities / Considerations: If you are experiencing metabolic, blood sugar, or weight-related concerns, standard medical evaluations typically explore several clinical possibilities, such as:
1. Insulin resistance or metabolic syndrome
2. Type 2 diabetes mellitus or prediabetes
3. Thyroid or hormonal dysfunctions (e.g., hypothyroidism, PCOS)

Category:

Description

• Product: Retatrutide appears to be an experimental triple-hormone receptor agonist (targeting GLP-1, GIP, and glucagon receptors) studied for weight management and metabolic health.
• Dosing Table in Image:
• Week 1 & Week 2: 3mg strength (20 units / 0.2ml), administered once weekly.
• Week 3 & Week 4: 4.5mg strength (30 units / 0.3ml), administered once weekly.
• Week 5 & Week 6: 7.5mg strength (50 units / 0.5ml), administered once weekly.

Important Medical & Safety Information

• Investigational Status: Retatrutide is not an FDA-approved or officially registered commercial medication for general public weight loss; it remains an investigational research peptide currently undergoing clinical trials (such as Phase 2/3 studies).
• Potential Risks & Side Effects: Compounds in this class (GLP-1/GIP/glucagon agonists) can cause gastrointestinal issues (nausea, vomiting, diarrhea, constipation), elevated heart rate, and other systemic effects. Because it is unapproved, manufacturing purity, sterility, and exact dosing concentrations in non-pharmaceutical research products can vary significantly.
• Possibilities / Considerations: If you are experiencing metabolic, blood sugar, or weight-related concerns, standard medical evaluations typically explore several clinical possibilities, such as:
1. Insulin resistance or metabolic syndrome
2. Type 2 diabetes mellitus or prediabetes
3. Thyroid or hormonal dysfunctions (e.g., hypothyroidism, PCOS)
• Treatment Options: Evidence-based approaches to metabolic and weight management generally involve:
1. Structured nutritional and lifestyle modification plans
2. FDA-approved, clinically validated metabolic medications (under direct medical supervision)
3. Comprehensive endocrinological or primary care monitoring
Medical Disclaimer: This information is for general educational purposes only and does not constitute medical advice, a diagnosis, or a prescription. Always consult a qualified healthcare provider or endocrinologist before starting, changing, or evaluating any peptide, hormone, or weight-loss regimen. Make sure to double-check any physical product labels or consult a pharmacist/doctor regarding specific concentrations and safety.

Reviews

There are no reviews yet.

Be the first to review “RE:TATRUTIDE”

Your email address will not be published. Required fields are marked *